- Home
- LTRN vs GDTC Comparison
LTRN vs GDTC Comparison
Compare LTRN & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- GDTC
- Stock Information
- Founded
- LTRN 2013
- GDTC 2018
- Country
- LTRN United States
- GDTC Singapore
- Employees
- LTRN N/A
- GDTC N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- LTRN Health Care
- GDTC Health Care
- Exchange
- LTRN Nasdaq
- GDTC Nasdaq
- Market Cap
- LTRN 49.9M
- GDTC 24.2M
- IPO Year
- LTRN 2020
- GDTC 2023
- Fundamental
- Price
- LTRN $3.86
- GDTC $2.80
- Analyst Decision
- LTRN Strong Buy
- GDTC
- Analyst Count
- LTRN 1
- GDTC 0
- Target Price
- LTRN $25.00
- GDTC N/A
- AVG Volume (30 Days)
- LTRN 177.7K
- GDTC 193.1K
- Earning Date
- LTRN 11-06-2025
- GDTC 01-01-0001
- Dividend Yield
- LTRN N/A
- GDTC N/A
- EPS Growth
- LTRN N/A
- GDTC N/A
- EPS
- LTRN N/A
- GDTC N/A
- Revenue
- LTRN N/A
- GDTC $573,193.00
- Revenue This Year
- LTRN N/A
- GDTC $5.37
- Revenue Next Year
- LTRN N/A
- GDTC N/A
- P/E Ratio
- LTRN N/A
- GDTC N/A
- Revenue Growth
- LTRN N/A
- GDTC 63.03
- 52 Week Low
- LTRN $2.55
- GDTC $1.65
- 52 Week High
- LTRN $6.12
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- LTRN 40.27
- GDTC 72.45
- Support Level
- LTRN $3.89
- GDTC $1.95
- Resistance Level
- LTRN $4.58
- GDTC $2.43
- Average True Range (ATR)
- LTRN 0.31
- GDTC 0.32
- MACD
- LTRN -0.06
- GDTC 0.07
- Stochastic Oscillator
- LTRN 6.64
- GDTC 50.84
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.